Epalrestat
Epalrestat CAS n-ro: 82159-09-9
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
Epalrestat kutimas malhelpi, plibonigi kaj trakti periferian neuropation (entumecimiento, doloro), vibran parestezon kaj koranomalion asociitan kun diabeto. SPECIFO
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
Epalrestat kutimas malhelpi, plibonigi kaj trakti periferian neuropation (entumecimiento, doloro), vibran parestezon kaj koranomalion asociitan kun diabeto. SPECIFO
| P rodukta nomo | Epalrestat |
| CAS | 82159-09-9 |
| MF: | C15H13NO3S2 |
| MW: | 319.4 |
Skribu vian mesaĝon ĉi tie kaj sendu ĝin al ni
